Citadel Advisors’s Cambria Cannabis ETF TOKE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$63.9K Buy
+12,500
New +$71.5K ﹤0.01% 12299
2025
Q2
Sell
-600
Closed -$2.7K 15099
2025
Q1
$2.7K Buy
+600
New +$2.91K ﹤0.01% 14017
2024
Q3
Sell
-10,000
Closed -$56.9K 15260
2024
Q2
$56.9K Buy
10,000
+900
+10% +$5.54K ﹤0.01% 11617
2024
Q1
$58.4K Buy
+9,100
New +$52.9K ﹤0.01% 12027
2023
Q2
Sell
-7,300
Closed -$45.6K 15247
2023
Q1
$45.6K Buy
7,300
+6,800
+1,360% +$45.8K ﹤0.01% 12280
2022
Q4
$3.35K Buy
+500
New +$3.6K ﹤0.01% 14227

Other funds holding TOKE

Citadel Advisors's TOKE Position: Q2 2025 in Review

Citadel Advisors sold out of Cambria Cannabis ETF (TOKE) in Q2 2025, closing a stake of 3,714 shares — an estimated $16.7K sold.

Citadel Advisors first reported a position in TOKE in Q2 2022 and held it in 6 quarters. The position peaked at $213K in Q4 2022. 16 funds tracked by Wall St. Rank hold TOKE as of Q2 2025.

  • Citadel Advisors reported no remaining Cambria Cannabis ETF position as of Q2 2025 after selling out during the quarter.
  • Citadel Advisors sold 3,714 Cambria Cannabis ETF shares in Q2 2025, an estimated $16.7K.
  • Citadel Advisors first reported a position in Cambria Cannabis ETF in Q2 2022 and held it in 6 quarters.
  • Citadel Advisors's Cambria Cannabis ETF position peaked at $213K in Q4 2022.
  • 16 funds tracked by Wall St. Rank held Cambria Cannabis ETF as of Q2 2025.

Based on Citadel Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.